Yantai Dongcheng Biochemicals Co.,Ltd.’s Net Profit Rose 10.2% in First Three Quarters of 2022
Listen to the full version

Yantai Dongcheng Biochemicals Co.,Ltd. (烟台东诚药业集团股份有限公司) (002675.SZ) reported a net profit of 382.8 million yuan in the first three quarters of 2022, up 10.2% year-on-year.
Meanwhile, the company posted 2.7 billion yuan in revenue, down 1.9% year-on-year.
At the end of the reporting period, it had 8.5 billion yuan in total assets and 2.8 billion yuan in total liabilities, with a liability-to-asset ratio of 32.9%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR